Search

Your search keyword '"Ess, Sm"' showing total 21 results

Search Constraints

Start Over You searched for: Author "Ess, Sm" Remove constraint Author: "Ess, Sm"
21 results on '"Ess, Sm"'

Search Results

1. Worldwide comparison of survival from childhood leukaemia for 1995–2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children from 198 registries in 53 countries

2. Cancer prevalence estimates in Europe at the beginning of 2000

3. Erratum to 'The histology of ovarian cancer: Worldwide distribution and implications for international survival comparisons (CONCORD-2)' [Gynecol. Oncol. 144 (2017) 405-413]

4. The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2)

5. Erratum to 'Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)' [Gynecol. Oncol. 144 (2017) 396–404]

6. Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)

7. Medical-economical aspects of high sensitivity C-reactive protein assay for the prediction of coronary heart disease: an analysis in Germany and Italy

8. Worldwide comparison of survival from childhood leukaemia for 1995–2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children from 198 registries in 53 countries

11. Testicular germ-cell tumours and penile squamous cell carcinoma: Appropriate management makes the difference

12. Impact of subtypes and comorbidities on breast cancer relapse and survival in population-based studies.

13. Epidermal growth factor receptor and anaplastic lymphoma kinase testing and mutation prevalence in patients with advanced non-small cell lung cancer in Switzerland: A comprehensive evaluation of real world practices.

14. Surgical treatment of early stage breast cancer in elderly: an international comparison.

15. Prevalence and direct medical costs of end-stage renal disease in patients with type 2 diabetes mellitus in Switzerland for 2001.

16. Cost-effectiveness of a pneumococcal conjugate immunisation program for infants in Switzerland.

17. European healthcare policies for controlling drug expenditure.

18. Economic evaluation of immunization strategies.

19. High dose lisinopril in heart failure: economic considerations.

20. Medical-economical aspects of high sensitivity C-reactive protein assay for the prediction of coronary heart disease. An analysis in Germany and Italy.

21. Experimental study on the fibrogenic properties of different types of alumina.

Catalog

Books, media, physical & digital resources